Skip to main content

RT @RichardPAConway: Botson et al. 152 patient RCT. MTX combo with pegloticase (to decrease antidrug abs). 6-month respo

Social Author Name
Richard Conway
Tweet Content
Botson et al. 152 patient RCT. MTX combo with pegloticase (to decrease antidrug abs). 6-month response (sUA<6 mg/dL) 71% vs 39%. Infusion reactions 3% vs 31%. @RheumNow #EULAR2022 OP0171 https://t.co/N29kYT3xkR https://t.co/Z4dUMD4Tt3
Show on Archive Page
On
Display in Search Results
On
PDQ
Off